1. What criteria should be used to evaluate which results to return? |
2. Should CLIA confirmation be required? |
3. What is the best way to empower research participants to make the best decisions for themselves about which results to receive? |
a. What processes should be used to document participant preferences for return of results (which was not done originally) and obtain informed consent? |
b. What is the role of pre-test genetic counseling? |
c. What approaches should be used for genetics education? |
4. What processes should be used to communicate results to the participants? |
a. What is the role of the physician? |
b. What is the role of disclosure/post-test genetic counseling? |
5. How should the multi-site nature of the project be handled, given that multiple IRBs are involved and contact information for many participants is maintained at the sites? |
6. How should changes in interpretation of the results over time be handled? Should they be communicated to research participants and if so, how? |
7. What approaches can/should be used to provide ongoing information and support? |
8. How should costs be handled, given that the project’s budget did not include funds for return of results? |